![]()
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Tetanea | Sanofi Ltd. | 1,500 i.u | 1s | 1s KES 584
20s KES 9,199 |
|||
| Anti-tetanus serum More info | |
|---|---|
| Mode Of Action | For anti-D the mechanism of inhibition of antibody synthesis is unclear, but rapid destruction and clearance of Rh-positive cells from the circulation seem to play a role. |
| Drug Indication | Prophylaxis against suspected contamination by clostridium tetani |
| Precautions | Active immunization carried out at the same time. Avoid other vaccines for at least 3 months. |
| Side Effects | Anaphylactic reactions, headache, fever, flush, chills. IgA sensitization, efficacy of other vaccines impaired. |
| Special Information | Immediate antibodies against tetanus |
| Drug Category | DRUGS ACTING ON INFECTIONS |
| Drug Sub-Category | Sera & Immunoglobulins |